Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,930.00
Bid: 11,936.00
Ask: 11,940.00
Change: -98.00 (-0.81%)
Spread: 4.00 (0.034%)
Open: 12,052.00
High: 12,094.00
Low: 11,880.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Oil drops as inventories and COVID vaccine halt threaten demand

Tue, 16th Mar 2021 05:48

* Germany, France, Italy suspend use of AstraZeneca shot

* Move threatens EU's already slow vaccination campaign

* U.S. inventories seen rising in data releases this week

* U.S. refineries take time to recover from 'big freeze'
(Updates prices)

By Shadia Nasralla

LONDON, March 16 (Reuters) - Oil prices fell for a third day
on Tuesday, as a recovery in demand was threatened by rising
U.S. inventories and moves by Germany, France and some other
European states to suspend the use of a major coronavirus
vaccine.

Brent was down $1.11 cents, or 1.6%, at $67.77 a
barrel by 1325 GMT. U.S. crude fell $1.17, or 1.7%, at
$64.22.

Germany, France and Italy said they would suspend the use of
the Oxford/AstraZeneca vaccine after reports about
possible serious side effects, although the World Health
Organization said there was no established link to the vaccine.

The moves deepen concerns about the slow pace of
vaccinations in the European Union, threatening an economic
recovery and fuel demand.

The pandemic eviscerated demand for oil. Prices have
recovered to levels seen before the global health crisis, but
gains have been capped as vaccine rollouts have proceeded slowly
in many countries.

In the United States, crude inventories are also rising as
refineries have taken time to recover fully from a "big freeze"
that halted their operations in Texas and elsewhere.

"Short-term direction will be set by the weekly U.S.
inventory reports," PVM analysts said in a note, adding that the
dollar's strength against other currencies also weighed on the
oil price.

Analysts expect another week of inventory gains when the
American Petroleum Institute, an industry group, reports on
crude stockpiles on Tuesday, followed by official numbers from
the Department of Energy on Wednesday.

Inventories rose by 12.8 million barrels in the week to
March 5, against forecasts for a rise of less than 1 million
barrels.

(Additional reporting by Aaron Sheldrick; Editing by Susan
Fenton and Edmund Blair)

More News
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.